American Cancer Society Cancer Action Network (ACS CAN) shared a post on LinkedIn:
“A new paper in Cambridge University Press’s Journal of Clinical and Translational Science finds that travel distance to National Cancer Institute (NCI)-funded sites remains a key barrier for patients wanting to participate in Clinical Trials or research at these locations.
‘The evidence is clear that research opportunities for patients with cancer are not equally accessible to all, and multiple administrations have identified the same solution to this barrier,’ says Sharon Shriver, Ph.D., Senior Analyst at ACS CAN and lead author.
‘Public policy and public funding can expand research opportunities into more rural areas where cancer incidence and mortality are higher than in urban areas. We hope that our study will help make the case with policymakers that now is the time for broadening the base of institutions receiving research infrastructure support.’
Read more:”
More from American Cancer Society on OncoDaily.